Table: begin end state 1 26 cytoplasmic 27 45 transmembrane 46 61 non-cytoplasmic 62 85 transmembrane 86 96 cytoplasmic 97 116 transmembrane 117 121 non-cytoplasmic 122 143 transmembrane 144 159 cytoplasmic 160 185 transmembrane 186 190 non-cytoplasmic 191 210 transmembrane 211 259 cytoplasmic 260 278 transmembrane 279 297 non-cytoplasmic 298 318 transmembrane 319 326 cytoplasmic 327 345 transmembrane 346 351 non-cytoplasmic 352 379 transmembrane 380 391 cytoplasmic 392 411 transmembrane 412 422 non-cytoplasmic 423 446 transmembrane 447 463 cytoplasmic
Input: >17726 FitnessBrowser__Keio:17726 MLAFLNQVRKPTLDLPLEVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTY GLSMTQLGMIGLGFSITYGVGKTLVSYYADGKNTKQFLPFMLILSAICMLGFSASMGSGS VSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGTFLGFWNISHNLGGAGAAGVAL FGANYLFDGHVIGMFIFPSIIALIVGFIGLRYGSDSPESYGLGKAEELFGEEISEEDKET ESTDMTKWQIFVEYVLKNKVIWLLCFANIFLYVVRIGIDQWSTVYAFQELKLSKAVAIQG FTLFEAGALVGTLLWGWLSDLANGRRGLVACIALALIIATLGVYQHASNEYIYLASLFAL GFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPVFGLT GWAGTFAALDIAAIGCICLMAIVAVMEERKIRREKKIQQLTVA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server